Everolimus (RAD001) activity in renal and hepatocellular carcinoma cells resistant to sunitinib and sorafenib

被引：0
|
作者：
Serova, Maria [1 ,2 ]
Riveiro, Maria Eugenia [1 ,2 ]
Dokmak, Safi [1 ,2 ]
Faivre, Sandrine [1 ,2 ]
Raymond, Eric [1 ,2 ]
机构：
[1] Beaujon Univ Hosp, RayLab, U728, Clichy, France
[2] Beaujon Univ Hosp, Dept Med Oncol, Clichy, France
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-4488
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4488
引用
收藏
页数：1
相关论文
共 50 条
  • [31] mTOR inhibitor RAD001 (everolimus) induces apoptotic, not autophagic cell death, in human nasopharyngeal carcinoma cells
    Cai, Yuchen
    Xia, Qing
    Su, Quanguan
    Luo, Rongzhen
    Sun, Yueli
    Shi, Yanxia
    Jiang, Wenqi
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 31 (04) : 904 - 912
  • [32] Sorafenib and everolimus (RAD001) in the treatment of patients with advanced clear cell renal carcinoma (RCC): A Sarah Cannon Research Institute phase I/II trial.
    Waterhouse, D. M.
    Penley, W. C.
    Webb, C. D.
    Greco, F. A.
    Burris, H. A.
    Hainsworth, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [33] RAD001 (everolimus) induces autophagy in acute lymphoblastic leukemia
    Crazzolara, Roman
    Bradstock, Kenneth F.
    Bendall, Linda J.
    AUTOPHAGY, 2009, 5 (05) : 727 - 728
  • [34] Activity of everolimus (RAD001) in relapsed and/or refractory multiple myeloma: a phase I study
    Guenther, Andreas
    Baumann, Philipp
    Burger, Renate
    Kellner, Christian
    Klapper, Wolfram
    Schmidmaier, Ralf
    Gramatzki, Martin
    HAEMATOLOGICA, 2015, 100 (04) : 544 - 550
  • [35] Preclinical evaluation of combined TKI258 and RAD001 in hepatocellular carcinoma
    Wong, Chi Hang
    Yeo, Winnie
    Lui, Vivian
    Lau, Cecilia P. Y.
    Hui, Connie W. C.
    Chan, Anthony T. C.
    Chan, Stephen L.
    CANCER RESEARCH, 2012, 72
  • [36] Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinoma
    Chan, Stephen L.
    Wong, Chi-Hang
    Lau, Cecilia P. Y.
    Zhou, Qian
    Hui, Connie W. C.
    Lui, Vivian W. Y.
    Ma, Brigette B. Y.
    Chan, Anthony T. C.
    Yeo, Winnie
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (06) : 1417 - 1425
  • [37] Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinoma
    Stephen L. Chan
    Chi-Hang Wong
    Cecilia P. Y. Lau
    Qian Zhou
    Connie W. C. Hui
    Vivian W. Y. Lui
    Brigette B. Y. Ma
    Anthony T. C. Chan
    Winnie Yeo
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1417 - 1425
  • [38] Everolimus affects vasculogenic mimicry in renal carcinoma resistant to sunitinib
    Serova, Maria
    Tijeras-Raballand, Annemilai
    Dos Santos, Celia
    Martinet, Matthieu
    Neuzillet, Cindy
    Lopez, Alfred
    Mitchell, Dianne C.
    Bryan, Brad A.
    Gapihan, Guillaume
    Janin, Anne
    Bousquet, Guilhem
    Riveiro, Maria Eugenia
    Bieche, Ivan
    Faivre, Sandrine
    Raymond, Eric
    de Gramont, Armand
    ONCOTARGET, 2016, 7 (25) : 38467 - 38486
  • [39] Phase II study of everolimus (RAD001) in metastatic transitional cell carcinoma (TCC) of the urothelium
    Milowsky, M. I.
    Regazzi, A. M.
    Garcia-Grossman, I. R.
    Trout, A.
    Flaherty, A.
    Gerst, S.
    Bajorin, D. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [40] Phase II study of everolimus (RAD001) in metastatic transitional cell carcinoma (TCC) of the urothelium
    Milowsky, M. I.
    Trout, A.
    Regazzi, A. M.
    Garcia-Grossman, I.
    Flaherty, A.
    Tickoo, S.
    Al-Ahmadie, H.
    Bajorin, D. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345